CVF, LLC SEC EDGAR Filings (CIK 0001112278)

SEC EDGAR filings, ownership reports, and insider transactions for CVF, LLC.

Business address
222 North Lasalle Street, Suite 2000, Chicago, IL, 60601
Top holdings (ownership)
GUTS
Top holdings (Schedule 13G)
NARI
Get insider transactions for this reporting owner
CVF, LLC has filed 29 SEC EDGAR filings since 21 Apr 2000

Latest Filings

Recent SEC filings for CVF, LLC including SCHEDULE 13G/A, SC 13G/A, SC 13G and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 12 Feb 2025
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 07 Nov 2024
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 14 Feb 2024
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Feb 2024 06 Feb 2024 001-41942
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 01 Feb 2024 01 Feb 2024 001-41942
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 10 Feb 2023
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 10 Feb 2023
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 10 Feb 2022
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 10 Feb 2022
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 05 Feb 2021
SC 13G Open SC 13G document View SEC filing for SC 13G COMPLETE SUBMISSION TEXT FILE 20 Nov 2020
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G/A 09 Feb 2018
3 Open 3 document View SEC filing for 3 FORM 3 - 19 Jul 2017 19 Jul 2017 001-38150
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 Jul 2017 05 Jul 2017 001-38130
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 28 Jun 2017 28 Jun 2017 001-38130
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G AMENDMENT NO. 2 10 Feb 2017
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A CERULEAN PHARMA INC. SCHEDULE 13G/A 10 Feb 2016
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A GENOCEA BIOSCIENCES, INC. SCHEDULE 13G/A 10 Feb 2016
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 09 Apr 2015 07 Apr 2015 001-36395
SC 13G Open SC 13G document View SEC filing for SC 13G CERULEAN PHARMA INC. SCHEDULE 13G 17 Feb 2015
SC 13G Open SC 13G document View SEC filing for SC 13G GENOCEA BIOSCIENCES, INC. SCHEDULE 13G 17 Feb 2015
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 16 Apr 2014 15 Apr 2014 001-36395
3 Open 3 document View SEC filing for 3 PRIMARY DOCUMENT 10 Apr 2014 10 Apr 2014 001-36395

About this filer

CVF, LLC files with the SEC under CIK 0001112278. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages